Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-01-01 @ 3:34 AM
Study NCT ID:
NCT00807859
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2008-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-11
First Submit QC Date:
None
Study First Post Date:
2008-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL